Hormonal Metabolic

Semaglutide

GLP-1 receptor agonist for type 2 diabetes and weight management (Ozempic/Wegovy).

FormulaC187H291N45O59 MW4113.58 Da Injectable

Related Peptides

Triple agonist (GLP-1/GIP/glucagon) for exceptional weight loss — the most potent investigational obesity drug to date.

Available for Research

Research-grade Semaglutide available from NuVion.

Research use only. For Qualified Researchers.

Injectable

⚠ For research use only. Not medical advice. Consult a licensed healthcare professional before use.